BINOSTO® (alendronate sodium) effervescent tablet for oral solution 70 mg is big news in osteoporosis therapy! Be aware of the latest—check back here to find postings of new press releases and important news about BINOSTO.
For more information about BINOSTO or Mission Pharmacal, please contact:
Drew Deeter DEETER Strategic Public Relations 111 East Court Street Doylestown, PA 18901 215.348.3890 [email protected]
This material is intended to provide basic information and is not medical advice. All medical advice, diagnosis, and treatment should be obtained from your physician.
The product information provided in this site is intended for residents of the United States.
© 2017 Mission Pharmacal Company. All rights reserved.
Mission Pharmacal Company | San Antonio, TX 78230-1355 | Phone: 210.696.8400
This content comes from a hidden element on this page.
If you try to open a new ColorBox while it is already open, it will update itself with the new content.
Updating Content Example:
Click here to load new content